Madrigal Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · West Conshohocken, PA
MDGL chart
What traders are saying about $MDGL
Latest postsMadrigal Pharmaceuticals, Inc. news
- Madrigal Pharmaceuticals (MDGL) Nears Earnings And Rezdiffra Data, Is 36% Undervalued Enough?
Simply Wall Street ·
- BofA cuts target for Madrigal Pharmaceuticals stock to USD 533.00
ad-hoc-news.de ·
- Will Madrigal (MDGL) Report Negative Earnings Next Week? What You Should Know
Yahoo Finance ·
- Madrigal to Present Multiple Abstracts at AASLD's The Liver Meeting 2026, Including New Real-World Evidence Reinforcing Rezdiffra as a Foundational Therapy for MASH
Yahoo Finance ·
- More than 12,000 patients are included in one real-world dataset on Madrigal's liver drug.
Stock Titan ·
- Madrigal Sets November 3 Earnings Report as MASH Drug Expands
MyChesCo ·
- Madrigal Pharmaceuticals (NDQ:MDGL): It's Got The First Scalable Treatment for a Disease We Barely Diagnose!
Stocks Down Under ·
- Can Corcept Therapeutics Stock Rally 40% After This Dip?
trefis.com ·
- UBS raises target for Madrigal Pharmaceuticals stock to USD 735.00
ad-hoc-news.de ·
- Madrigal Pharmaceuticals, Inc. Estimates – NASDAQ:MDGL
TradingView ·
- Madrigal Pharmaceuticals (MDGL) Stock Looks Undervalued After A Very Large Five Year Run
Simply Wall Street ·
- Shapiro Administration Highlights Importance of New Innovate in PA 2.0 Program During Opening of Madrigal Pharmaceuticals’ Headquarters in Montgomery County
PA Department of Community & Economic Development (.gov) ·
Madrigal Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $958.4M | $180.1M | $0 | $0 |
| Net income | -$288.3M | -$465.9M | -$373.6M | -$295.3M |
| Diluted EPS | $-10.15 | $-17.31 | $-17.33 | $-17.23 |
| Total assets (year end) | $1.26B | $1.04B | $640.5M | $362.6M |
| Cash and equivalents (year end) | $198.7M | $100.0M | $99.9M | $331.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Madrigal Pharmaceuticals, Inc.
- Ticker
- MDGL (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- West Conshohocken, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1157601
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Frequently asked questions
What exchange is Madrigal Pharmaceuticals, Inc. listed on?
Madrigal Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol MDGL.
What industry is Madrigal Pharmaceuticals, Inc. in?
Madrigal Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Madrigal Pharmaceuticals, Inc. headquartered?
Madrigal Pharmaceuticals, Inc.'s business address on file with the SEC is in West Conshohocken, PA.
When does Madrigal Pharmaceuticals, Inc.'s fiscal year end?
Madrigal Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Madrigal Pharmaceuticals, Inc. report?
Madrigal Pharmaceuticals, Inc. reported $958.4M in revenue for calendar year 2025, according to its SEC filings.